|
2024
|
Invention
|
Recombinant proteins and their therapeutic uses.
A recombinant protein expressing one or more hu... |
|
2022
|
Invention
|
Methods of using anti-egf antibodies to augment the activity of braf and kras inhibitors. Embodim... |
|
|
Invention
|
Self-assembling synthetic proteins.
The present disclosure provides for a synthetic immunogenic ... |
|
2021
|
Invention
|
Recombinant proteins and their therapeutic uses. A recombinant protein expressing one or more hum... |
|
|
Invention
|
Methods and compositions for inhibition of egf/egfr pathway in combination with tyrosine kinase i... |
|
2020
|
Invention
|
Methods and compositions for use of growth factor antibodies in combination with non-tyrosine tar... |
|
|
Invention
|
Stabilized chimeric synthetic proteins and therapeutic uses thereof.
The disclosure relates to c... |
|
|
Invention
|
Stabilized chimeric synthetic proteins and therapeutic uses thereof. The disclosure relates to co... |
|
|
Invention
|
Self-assembling synthetic proteins. The present disclosure provides for a synthetic immunogenic p... |
|
2019
|
Invention
|
Methods and compositions for inhibition of egf/egfr pathway in combination with anaplastic lympho... |
|
|
Invention
|
Methods and compositions for inhibition of egf/egfr pathway in cobination with anaplastic lymphom... |
|
2018
|
Invention
|
Synthetic proteins and therapeutic uses thereof. The present disclosure relates to compositions a... |
|
2015
|
Invention
|
Epidermal growth factor fusion proteins with mutant cholera toxin b subunits. The present disclos... |
